Strategic Sequencing in Oligometastatic Cancer Treatment: A Closer Look at the SABR-5 Trial’s Upfront vs. Delayed Systemic Therapy
Stella Richards Introduction The journey toward optimizing cancer treatment is a complex one, with physicians and researchers…
Read More